The Biden administration unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare. It kicks off the second phase of a landmark provision in ...
The Biden administration said Friday it is targeting 15 drugs in the second-ever round of price negotiations under Medicare, with blockbuster drugs Ozempic and Wegovy topping the list. The list of ...
CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket costs at $2 per month for select medications. The initial list includes common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results